To study the effectiveness of yogam therapy in the management of diabetes mellittus

Preclinical and comparative clinical study of Maruthampattai kudineer and yogam therapy in the management of Madhumegam(Type II diabetes mellitus)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013163

Enrollment

Registered

2018-04-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient with fasting blood sugar less than 150 mg/dl, post postprandial less than 250 mg/dl and Hba1c less than 6 to 8

Interventions

Intervention1: Maruthampattai Kudineer (internal medicine): Maruthampattai kudineer is a polyherbal formulation in a dosage of 60 ml (b.d) for 90 days Control Intervention1: Yogam therapy: Suriyanamas

Eligibility

Inclusion criteria

Inclusion criteria: 1. Symptoms of polyuria, polyphagia, nocturia, polydypsia. 2. Blood glucose level: fasting blood glucose- less than 150 mg/dl, postprandial level less than 250 mg/dl and Hba1c less 6 to 8. 3. Non insulin dependent diabetes mellitus.

Exclusion criteria

Exclusion criteria: Blood glucose level: fasting blood glucose- less than 151 mg/dl, postprandial level greater than 250 mg/dl and Hba1c above 8.1 insulin dependent diabetes mellitus. patient with diabetic complication diabetic foot,retinopathy etc. any other serious systemic illness pregnancy and lactation

Design outcomes

Primary

Measure	Time frame
To observe the changes in the HbA1cTimepoint: 1 - 90 days	—

Secondary

Measure	Time frame
To observe the changes in fasting and postprandial blood glucose levelTimepoint: 1-90 days	—

Countries

India

Contacts

Public ContactN J Muthukumar

National Institute of Siddha

njmuthu@hotmail.com9962006843

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026